Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
An international team of researchers has found that acute respiratory distress syndrome (ARDS) is under-recognised, and that people with the condition are often undertreated.
ARDS is a life-threatening condition in which the lungs are unable to properly provide enough oxygen for the rest of the body.
The study, published in the Journal of the American Medical Association, involved 459 hospital intensive care departments from 50 different countries, spanning five continents.
Researchers focussed on a 4-week period in winter 2014. During this time, they monitored the 3022 people admitted to the intensive care departments who met the criteria for having ARDS.
The scientists found that 2377 of these patients developed ARDS within their first 48 hours in intensive care, and received treatment.
On average, 51% of people with mild ARDS and 78.5% with severe ARDS had their cases recognised by healthcare professionals. It was also noted that people with ARDS were often not offered the recommended or most appropriate treatments.
The researchers state that their findings show that ARDS is often under-recognised by healthcare professionals, and that management of people with the condition could be improved.
Read our information page on acute respiratory distress syndrome.
Sign up to our free monthly newsletter to get the latest information and research news on lung conditions, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79